Activity of a Phage Collection Against Staphylococci from Periprosthetic Joint Infections
Open Access
- 1 October 2025
- journal article
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 10 (4)
Abstract
Background: Phages are being assessed for treatment of periprosthetic joint infection (PJI). Staphylococci are the most common cause of PJI. Phages are traditionally considered to be strain-specific and restricted to specific species. We aimed to assess the in vitro activity of a collection of staphylococcal phages against a selection of clinical Staphylococcus isolates recovered from PJI over a 20-year period. Methods: The activity of 37 staphylococcal phages was evaluated against 204 staphylococcal isolates, including 102 Staphylococcus aureus, 81 Staphylococcus epidermidis , and 21 Staphylococcus lugdunensis , using a tetrazolium dye–based metabolic assay. Standardized inocula of bacteria and phage were incubated over 48 hours. Growth inhibition ≥8 hours was considered indicative of phage activity. Results: A total of 7,548 phage-isolate pairs were assessed. Overall, 31 of 37 phages had activity against at least 1 isolate. The most broadly active phage showed activity against 50 of 195 isolates (26%) tested. Twenty-three phages showed cross-species activity, with 11 phages active against all 3 Staphylococcus species, and 12 phages active against 2 species. Of all S. aureus isolates tested, 61% were susceptible to at least 1 phage, while 31% and 76% of S. epidermidis and S. lugdunensis isolates were susceptible to at least 1 phage, respectively. Conclusions: This is the largest library of phages evaluated against staphylococci from PJI. Results show that staphylococcal phages can have cross-species activity, suggesting that phage libraries may offer cross-species coverage of clinically encountered staphylococcal isolates from PJI. Level of Evidence: Level V . Mechanism-based reasoning. See Instructions for Authors for a complete description of levels of evidence.Keywords
Funding Information
- Adaptive Therapeutics Inc
This publication has 49 references indexed in Scilit:
- Abolishment of morphology-based taxa and change to binomial species names: 2022 taxonomy update of the ICTV bacterial viruses subcommitteeArchives of Virology, 2023
- Microbiology of hip and knee periprosthetic joint infections: a database studyClinical Microbiology and Infection, 2022
- Multi-species host range of staphylococcal phages isolated from wastewaterNature Communications, 2021
- Coevolution between bacterial CRISPR-Cas systems and their bacteriophagesCell Host & Microbe, 2021
- Phage Therapy for Limb-threatening Prosthetic KneeKlebsiella pneumoniaeInfection: Case Report and In Vitro Characterization of Anti-biofilm ActivityClinical Infectious Diseases, 2020
- Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapyCurrent Opinion in Microbiology, 2019
- Silviavirus phage ɸMR003 displays a broad host range against methicillin-resistant Staphylococcus aureus of human originApplied Microbiology and Biotechnology, 2019
- Characterization of novelStaphylococcus aureuslytic phage and defining their combinatorial virulence using the OmniLog® systemBacteriophage, 2016
- Intragenus generalized transduction in Staphylococcus spp. by a novel giant phageThe ISME Journal, 2014
- Phage Host Range and Efficiency of Plating2009